Repatha on Horizon Medicare Blue Rx Enhanced (S5993-003)
evolocumab
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 6 per 28 days.
$340.19
Patient pays / month, after deductible
$500.19
Patient pays / month, before the $200.00 deductible
$1,020.57
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
REPATHA 140 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,700.95 for a month. Other covered strengths are listed below.
Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| REPATHA 140 mg/mL Injection, Solution | 3 | $345.66 | PA · 6 per 28 days |
| REPATHA 140 mg/mL Injection, Solution | 3 | $340.19 | PA · 6 per 28 days |
Other Non-statin cholesterol drugs on this plan
Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5993-003